🇺🇸 FDA
Pipeline program

Abexinostat

XYN-609

Phase 2 small_molecule active

Quick answer

Abexinostat for Non Hodgkin Lymphoma is a Phase 2 program (small_molecule) at Xynomic Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Xynomic Pharmaceuticals
Indication
Non Hodgkin Lymphoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials